Literature DB >> 11136322

Prospective evaluation of the morbidity of axillary clearance for breast cancer.

M Duff1, A D Hill, G McGreal, S Walsh, E W McDermott, N J O'Higgins.   

Abstract

BACKGROUND: Axillary clearance, despite its morbidity, retains an essential role in the management of patients with breast cancer. The aim of this prospective study was to document the development of arm swelling and limitation of shoulder movement following complete axillary clearance.
METHODS: One hundred patients who had axillary clearance to level III, for treatment of breast cancer, were followed prospectively for over 1 year. Arm volumes were measured using an optoelectronic volometer and shoulder movements with a goniometer.
RESULTS: Ten patients had significant arm swelling at 1 year. The swelling was mild in eight and moderate in two. No patient developed severe swelling. Reduced arm movements were noted in the first week after operation but had returned to normal at 6 months.
CONCLUSION: This study provided accurate documentation of the morbidity associated with axillary clearance, together with a reproducible method of arm volume measurement.

Entities:  

Mesh:

Year:  2001        PMID: 11136322     DOI: 10.1046/j.1365-2168.2001.01620.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?

Authors:  T P J Farrell; N C Adams; M Stenson; P A Carroll; M Griffin; E M Connolly; S A O'Keeffe
Journal:  Eur Radiol       Date:  2015-03-05       Impact factor: 5.315

2.  Axillary Lymph Node Evaluation Utilizing Convolutional Neural Networks Using MRI Dataset.

Authors:  Richard Ha; Peter Chang; Jenika Karcich; Simukayi Mutasa; Reza Fardanesh; Ralph T Wynn; Michael Z Liu; Sachin Jambawalikar
Journal:  J Digit Imaging       Date:  2018-12       Impact factor: 4.056

3.  Ultrasonic shears versus electrocautery in axillary dissection for breast cancer-a randomized controlled trial.

Authors:  Suraj Manjunath; Rakesh S Ramesh; Shivakumar K; Vipin Goel
Journal:  Indian J Surg Oncol       Date:  2014-04-09

4.  Stretching exercises to reduce symptoms of postoperative neck discomfort after thyroid surgery: prospective randomized study.

Authors:  Yuuki Takamura; Akira Miyauchi; Chisato Tomoda; Takashi Uruno; Yasuhiro Ito; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Nobuyuki Amino; Kanji Kuma
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Identification of Sentinel Lymph Nodes Using Contrast-Enhanced Ultrasound in Breast Cancer.

Authors:  Naresh Kumar Saidha; Rohit Aggarwal; Arijit Sen
Journal:  Indian J Surg Oncol       Date:  2017-06-17

6.  Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study.

Authors:  Dorit Tidhar; Michal Katz-Leurer
Journal:  Support Care Cancer       Date:  2009-06-03       Impact factor: 3.603

7.  High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study.

Authors:  Kelsey J Rosbach; Dongsuk Shin; Timothy J Muldoon; Mohammad A Quraishi; Lavinia P Middleton; Kelly K Hunt; Funda Meric-Bernstam; Tse-Kuan Yu; Rebecca R Richards-Kortum; Wei Yang
Journal:  Biomed Opt Express       Date:  2010-09-16       Impact factor: 3.732

8.  Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy.

Authors:  Nele Adriaenssens; Vincent Vinh-Hung; Geertje Miedema; Harijati Versmessen; Jan Lamote; Marian Vanhoeij; Pierre Lievens; Hilde van Parijs; Guy Storme; Mia Voordeckers; Mark De Ridder
Journal:  Breast Cancer (Auckl)       Date:  2012-07-30

9.  Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer.

Authors:  A Damera; A J Evans; E J Cornford; A R M Wilson; H C Burrell; J J James; S E Pinder; I O Ellis; A H S Lee; R D Macmillan
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.